Tissue Regenix Group Plc Capital Reinvestment Ratio
Tissue Regenix Group Plc capital reinvestment ratio. Tissue Regenix Group Plc (TRX) has a Capital Reinvestment Ratio of 0.11x as of December 2023, meaning it reinvests 0% of its operating cash flow (GBX1.36 Million) in capital expenditures (GBX153.75K). Check TRX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tissue Regenix Group Plc (2023–2023)
Capital reinvestment ratio of Tissue Regenix Group Plc from 2023 to 2023. This chart tracks Tissue Regenix Group Plc's Capital Reinvestment Ratio across 1 annual periods. Also explore Tissue Regenix Group Plc equity growth rate to track the company's year-over-year net asset growth rate.
Tissue Regenix Group Plc Capital Reinvestment Ratio by Year (2023–2023)
Tissue Regenix Group Plc capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see Tissue Regenix Group Plc (TRX) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.83x | GBX1.04 Million | GBX863.00K | — |